Shionogi 1H FY18 (YE Mar'19) Results - First Glance
Key highlights 1H FY18 gross margins improved significantly to 85.3% from ~77% for the same period last year, primarily driven by 24% increase in...
306 Views
Best Japanese Performers in the Fall....
With summer starting to wind down, we put together a screen looking at names that have historically done the best from September through the end of...
408 Views
Opportunities in The (Overpriced) Japan Pharma Sector
As a defensive sector, Japan’s pharmaceutical sector has had an up-and-down time of it during the Abe era. In the early days of Abenomics, the...
140 Views
Innovation to Help Maintain HIV Franchise Market Share and Weather Harsh Domestic Market Conditions
Continuous innovation at HIV Franchise to not only help defend market share…. Concerns about competition from Gilead Sciences Inc (GILD US)'s,...
107 Views
Shionogi FY17 Earnings - First Glance
Shionogi & Co Ltd (4507 JP) reported FY17 results on May 09, 2018 HIV franchise royalties drove FY17 topline growth and gross margin expansion...
94 Views